Corcept Therapeutics (CORT) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.38% |
| Dec 31, 2025 | -1.35% |
| Sep 30, 2025 | -1.88% |
| Jun 30, 2025 | 4.41% |
| Mar 31, 2025 | -7.33% |
| Dec 31, 2024 | 0.91% |
| Sep 30, 2024 | 12.38% |
| Jun 30, 2024 | 11.95% |
| Mar 31, 2024 | 8.72% |
| Dec 31, 2023 | 7.34% |
| Sep 30, 2023 | 12.07% |
| Jun 30, 2023 | 8.63% |
| Mar 31, 2023 | -1.88% |
| Dec 31, 2022 | -29.94% |
| Sep 30, 2022 | 20.26% |
| Jun 30, 2022 | 16.73% |
| Mar 31, 2022 | 39.03% |
| Dec 31, 2021 | 47.46% |
| Sep 30, 2021 | 63.79% |
| Jun 30, 2021 | 93.53% |
| Mar 31, 2021 | 315.41% |
| Dec 31, 2020 | 93.47% |
| Sep 30, 2020 | 106.97% |
| Jun 30, 2020 | 75.46% |
| Mar 31, 2020 | 52.41% |
| Dec 31, 2019 | 57.01% |
| Sep 30, 2019 | 44.89% |
| Jun 30, 2019 | 36.12% |
| Mar 31, 2019 | 27.06% |
| Dec 31, 2018 | 31.81% |
| Sep 30, 2018 | 29.39% |
| Jun 30, 2018 | 28.69% |
| Mar 31, 2018 | 28.07% |
| Dec 31, 2017 | 61.07% |
| Sep 30, 2017 | 29.62% |
| Jun 30, 2017 | 29.66% |
| Mar 31, 2017 | 19.11% |
| Dec 31, 2016 | 19.75% |
| Sep 30, 2016 | 19.15% |
| Jun 30, 2016 | 16.11% |
| Mar 31, 2016 | 69.42% |
| Dec 31, 2015 | 16.38% |
| Sep 30, 2015 | 38.98% |
| Jun 30, 2015 | 19.41% |